Adhesives Research to Present Hydrophilic Adhesive Technologies
|
By LabMedica International staff writers Posted on 03 Aug 2016 |

Image: Hydrophilic technologies for microfluidic devices (Photo courtesy of Adhesives Research).
Adhesives Research (AR; Glen Rock, PA, USA), a leading developer and manufacturer of high-performance pressure-sensitive adhesives, tapes, specialty coatings, films, and laminates, will hold a presentation at AACC 2016 on the range of opportunities for hydrophilic adhesive technologies, which are expanding as demand for microfluidic biological tests increases. They will also be presenting a range of custom tailored products, from devices that detect infectious diseases to test kits that monitor diabetes and blood coagulation.
Hydrophilic adhesive technologies reduce the surface tension of fluids, such as water, urine, or blood to allow for rapid flow from the inlet area to a remote reagent site within in vitro diagnostic (IVD) and microfluidic devices. Available as pressure-sensitive adhesives (PSAs), heat-seals, and coatings, the technology is compatible with sensitive chemistries, demonstrates strong bonding to low-surface energy plastics, provides tailorable hydrophilic properties to regulate capillary fill time, and can be customized by modifying thickness, choice of substrate, and release liner.
“Hydrophilic technology continues to be used in a variety of medical devices, including blood glucose and blood coagulation point-of-care, in-house, and environmental test kits,” said Herb Hand, a senior scientist with over 24 years pioneering research on hydrophilic adhesives and coatings at AR, who will lead the discussion. “The future of hydrophilic tapes includes components in molecular diagnostic devices and devices for the discovery of infectious diseases.”
AR leverages core competencies in chemical synthesis formulation and coating technologies to provide a gamut of custom tailored products for diverse applications around the world in the construction, industrial, electronics, automotive, medical, and pharmaceutical industries. AR also operates manufacturing facilities in Ireland and Colombia; has sales and marketing offices in Great Britain, Singapore and China; and sales representation in Japan and Taiwan.
The American Association for Clinical Chemistry (AACC; Washington, DC, USA) is an international scientific/medical society of over 8,000 clinical laboratory professionals, physicians, research scientists and more. The AACC annual meeting, which will be held from July 31st to August 4th at the Pennsylvania Convention Center in Philadelphia (USA), features five days of educational sessions on scientific, clinical, technical and management challenges facing laboratory professionals, as well as the world’s largest Clinical Lab Expo.
Related Links:
Adhesives Research
American Association for Clinical Chemistry
Hydrophilic adhesive technologies reduce the surface tension of fluids, such as water, urine, or blood to allow for rapid flow from the inlet area to a remote reagent site within in vitro diagnostic (IVD) and microfluidic devices. Available as pressure-sensitive adhesives (PSAs), heat-seals, and coatings, the technology is compatible with sensitive chemistries, demonstrates strong bonding to low-surface energy plastics, provides tailorable hydrophilic properties to regulate capillary fill time, and can be customized by modifying thickness, choice of substrate, and release liner.
“Hydrophilic technology continues to be used in a variety of medical devices, including blood glucose and blood coagulation point-of-care, in-house, and environmental test kits,” said Herb Hand, a senior scientist with over 24 years pioneering research on hydrophilic adhesives and coatings at AR, who will lead the discussion. “The future of hydrophilic tapes includes components in molecular diagnostic devices and devices for the discovery of infectious diseases.”
AR leverages core competencies in chemical synthesis formulation and coating technologies to provide a gamut of custom tailored products for diverse applications around the world in the construction, industrial, electronics, automotive, medical, and pharmaceutical industries. AR also operates manufacturing facilities in Ireland and Colombia; has sales and marketing offices in Great Britain, Singapore and China; and sales representation in Japan and Taiwan.
The American Association for Clinical Chemistry (AACC; Washington, DC, USA) is an international scientific/medical society of over 8,000 clinical laboratory professionals, physicians, research scientists and more. The AACC annual meeting, which will be held from July 31st to August 4th at the Pennsylvania Convention Center in Philadelphia (USA), features five days of educational sessions on scientific, clinical, technical and management challenges facing laboratory professionals, as well as the world’s largest Clinical Lab Expo.
Related Links:
Adhesives Research
American Association for Clinical Chemistry
Latest AACC 2016 News
- Molecular Test Detects Three Arboviruses in Plasma Samples
- Derived Exosomal Protein Biomarkers in Alzheimer’s Disease Diagnosis
- New Biochip Array Developed for ApoE4 Classification
- Cell-Free DNA Identifies Liver Transplant Patients with Acute Rejection
- New Method Tested for Early Diagnosis Pediatric Diabetic Nephropathy
- FDA-Cleared Automated Cell Counter for CSF Launched at AACC 2016
- Semen Analysis Portfolio with Two New Products Featured at AACC 2016
- Automation Solutions for Clinical Diagnostic Equipment Showcased at AACC 2016
- New Tubes Designed for Medium Sample Volumes
- Multi Sample Osmometer Improves Testing Efficiency
- Innovative Information System Optimizes Laboratory Processes
- Innovative eLearning Interface Seamlessly Connects Competency Data
- Cloud-Based Connectivity Platform Advances Decentralized Healthcare
- Point-of-Care Immunoassay Analyzer on Display at AACC Annual Meeting
- Assay for Determination of 17-OH Progesterone to Be Featured at AACC Annual Meeting
- Fully Automated HbA1c Analyzer Available for Inspection at AACC Annual Meeting
Channels
Clinical Chemistry
view channel
New CA19-9 Cutoff Value Helps Identify High-Risk Pancreatic Cancer Patients
Pancreatic ductal adenocarcinoma (PDAC) is frequently diagnosed at an advanced stage and remains one of the most lethal solid tumors. Clinicians commonly use serum carbohydrate antigen 19-9 (CA19-9) to... Read more
Blood-Based Biomarkers Show Promise for Psychosis Risk Prediction
Psychosis commonly emerges in adolescence or early adulthood and can severely disrupt social and occupational functioning. Hallucinations, delusions, and disorganized thinking often evolve gradually, hindering... Read moreMolecular Diagnostics
view channel
New RNA Origami Method Supports Faster Targeted Testing for Repeat Expansion Disorders
Repeat expansion disorders drive conditions such as myotonic dystrophy, Huntington’s disease, and amyotrophic lateral sclerosis (ALS), yet accurately sizing the mutated sequences remains difficult.... Read more
FDA Approves Expanded Liquid Biopsy Panel for Advanced Cancer Profiling
Timely, comprehensive tumor profiling helps clinicians make treatment selection decisions for patients with advanced cancer. Blood-based approaches can provide actionable insights from a simple draw and... Read moreHematology
view channel
Higher Ferritin Threshold May Improve Iron Deficiency Detection in Children
Iron deficiency in school-age children can affect brain development, learning, growth, and physical performance, yet early deficiency may be missed when screening focuses mainly on anemia.... Read more
Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is an aggressive blood cancer that most often affects older adults and still carries a poor prognosis despite therapeutic advances. Venetoclax-based regimens have improved... Read moreImmunology
view channel
Immune Enzyme Linked to Treatment-Resistant Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) affects nearly 3 million people in the United States and its prevalence continues to rise. Medications that target tumor necrosis factor (TNF)-alpha are widely used, but... Read more
Simple Blood Test Could Replace Biopsies for Lung Transplant Rejection Monitoring
Lung transplant recipients face some of the highest rates of acute cellular rejection, and routine surveillance often relies on repeated surgical biopsies. These procedures can cause complications such... Read moreMicrobiology
view channel
New AMR Assay Supports Rapid Infection Control Screening in Hospitals
As antimicrobial resistance spreads worldwide, healthcare-associated infections are placing a growing burden on hospitals, increasing the need for faster and broader diagnostic solutions.... Read more
Diagnostic Gaps Complicate Bundibugyo Ebola Outbreak Response in Congo
In eastern Democratic Republic of the Congo, communities are confronting a resurgence of Bundibugyo ebolavirus, a rarer species for which no vaccines or treatments have been approved. Ebola is a highly... Read more
Study Finds Hidden Mpox Infections May Drive Ongoing Spread
Mpox continues to circulate despite vaccination, and many cases show no known link to a symptomatic partner. The role of people without symptoms has remained uncertain, limiting clarity on how transmission persists.... Read more
Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals
Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read morePathology
view channel
Rapid AI Tool Predicts Cancer Spatial Gene Expression from Pathology Images
Gene expression profiling can inform tumor biology and treatment selection, but spatial assays remain costly and time-consuming. Results can take weeks and cost thousands of dollars, limiting large-scale... Read more
AI Pathology Test Receives FDA Breakthrough for Bladder Cancer Risk Stratification
Non–muscle invasive bladder cancer has highly variable outcomes, complicating surveillance and treatment planning. Risk assessment typically relies on stage, grade, and tumor size, leaving uncertainty... Read moreTechnology
view channel
AI-Enabled Assistant Unifies Molecular Workflow Planning and Support
Clinical laboratories and research groups face increasingly complex molecular workflows and expanding technical documentation spread across multiple systems. Fragmented digital tools can slow experiment... Read more
AI Tool Automates Validation of Laboratory Software Configuration Changes
Regulated laboratories face heavy documentation and requalification demands when software configurations change, slowing improvements and discouraging beneficial updates. A new capability now automates... Read moreIndustry
view channel
Strategic Collaboration Advances RNA Foundation Models for Precision Oncology
Bulk RNA sequencing is increasingly used to study tumor biology, but standard analyses often reduce results to gene-level summaries that miss important transcript variants and mutation patterns.... Read more









